A very influential family with deep political and financial connections to the Sacklers — the owners of Purdue Pharma — the family and company who are named as the driving force in the opioid ...

In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s ...

Purdue Pharma and its owners, the Sackler family, have negotiated a revised $7.4 billion settlement to resolve litigation over OxyContin's role in the opioid epidemic. This agreement follows the ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...

Purdue Pharma and the Sackler family members who own the company have agreed to pay up to $7.4 billion in a new settlement to lawsuits over the impact of the powerful prescription painkiller OxyContin ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...